Fernando López‐Ríos

11.7k citations

177 papers · 6.4k indexed · 1 hit paper · h-index 44

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 45
Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 17
- HER2/EGFR in Cancer Research 16
- Cancer Immunotherapy and Biomarkers 14
- Lung Cancer Research Studies 13
Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 52
- Lung Cancer Diagnosis and Treatment 13
Pathology and Forensic Medicine top 1%
Dermatology top 1%
- Cancer and Skin Lesions 12

Co-authors: Esther Conde Manuel Hidalgo Keith M. Kerr José Luis Rodríguez‐Peralto Manfred Dietel Montse Sánchez‐Céspedes Ana Suárez‐Gauthier Marc Ladanyi
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: The Lancet (1 paper)Journal of Clinical Oncology (16 papers)SHILAP Revista de lepidopterología (1 paper)
Partner nations: Spain United States United Kingdom

In The Last Decade

Fernando López‐Ríos

175 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Fernando López‐Ríos

Since Specialization

Citations

This map shows the geographic impact of Fernando López‐Ríos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando López‐Ríos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando López‐Ríos more than expected).

Fields of papers citing papers by Fernando López‐Ríos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando López‐Ríos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando López‐Ríos. The network helps show where Fernando López‐Ríos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fernando López‐Ríos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fernando López‐Ríos Line = papers co-authored together Fernando López‐Ríos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay SHILAP Revista de lepidopterología ·Ilaria Alborelli,Melanie Demes,Peter J. Wild,Susana Hernández,Fernando López‐Ríos,Olivier Bordone,Christophe Bontoux,Paul Hofman,Caterina De Luca,Giancarlo Troncone,Luisella Righi,Umberto Malapelle,Ricella Souza da Silva,Luı́s Cirnes,Fernando Schmitt,Erwin Keller,Philip Jermann,John Longshore,Lukas Bubendorf	2025	0
2	Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer Lung Cancer ·Paul Hofman,Petros Christopoulos,Nicky D’Haene,John R. Gosney,Nicola Normanno,Ed Schuuring,Ming‐Sound Tsao,Christine Quinn,James Russell,Katherine E. Keating,Fernando López‐Ríos	2025	1
3	NTRK gene fusion testing and management in lung cancer Cancer Treatment Reviews ·Matteo Repetto,Marina Chiara Garassino,Herbert H. Loong,Fernando López‐Ríos,Tony Mok,Solange Peters,David Planchard,Sanjay Popat,Erin R. Rudzinski,Alexander Drilon,Caicun Zhou	2024	7
4	Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC JTO Clinical and Research Reports ·Horacio Cabo,Marco Siringo,Esther Conde,Susana Hernández,Fernando López‐Ríos,Alicia Castelo-Loureiro,Esther García-Lorenzo,Javier Baena,Mercedes Herrera,Ana B. Enguita,Yolanda Ruano,Jon Zugazagoitia,Luis Paz‐Ares	2024	0
5	Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathology Scientific Reports ·Irene Carretero‐Barrio,Lara Pijuán,Adrián Illarramendi,Daniel Curto,Fernando López‐Ríos,Ángel Estébanez-Gallo,Josep Castellví,Sofía Granados-Aparici,D. Compañ-Quilis,Rosa Noguera,Isabel Esteban‐Rodríguez,Ignacio Sánchez-Güerri,Ana Delia Ramos-Guerra,Juan E. Ortuño,Pilar Garrido,María Jesús Ledesma-Carbayo,Amparo Benito,José Palacios	2024	1
6	A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma Translational Lung Cancer Research ·Susana Hernández,Esther Conde,Marta Alonso de la Varga,Adrián Illarramendi,Helena Bote de Cabo,Jon Zugazagoitia,Luis Paz‐Ares,Fernando López‐Ríos	2023	8
7	Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non–Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers JCO Precision Oncology ·Edurne Arriola,Reyes Bernabé,Rosario García Campelo,Michele Biscuola,Ana B. Enguita,Fernando López‐Ríos,Rafael C. Martinez,Laura Mezquita,Sarai Palanca,María Jesús Pareja,Jon Zugazagoitia,Natalia Arrabal,Juan F. Garcı́a,David Carcedo,Enrique de Álava	2023	26
8	Optimizing tissue stewardship in non‐small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists Histopathology ·Keith M. Kerr,Lukas Bubendorf,Fernando López‐Ríos,Farah Khalil,Sinchita Roy‐Chowdhuri,Philippe Joubert,Arndt Hartmann,Elena Guerini‐Rocco,Yasushi Yatabe,Paul Hofman,Wendy A. Cooper,Sanja Đačić	2023	8
9	Targeted Therapy Moves to Earlier Stages of Non-Small-Cell Lung Cancer: Emerging Evidence, Controversies and Future Challenges Future Oncology ·Xabier Mielgo-Rubio,M. Martín,Jordi Remón,Oliver Higuera,Virginia Calvo,J.R. Jarabo,Esther Conde,J. Luna,Mariano Provencio,Javier de Castro,Fernando López‐Ríos,Florentino Hernándo,Felipe Couñago	2021	16
10	FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy EBioMedicine ·Àlvaro Quintanal-Villalonga,Irene Ferrer,Elizabeth Guruceaga,Cristina Cirauqui,Ángela Marrugal,Laura Ojeda,Santiago Garcia Borrego,Jon Zugazagoitia,Sandra Muñoz-Galván,Fernando López‐Ríos,Luis M. Montuenga,Silvestre Vicent,Sonia Molina‐Pinelo,Amancio Carnero,Luis Paz‐Ares	2020	17
11	Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers Cancers ·Xabier Mielgo-Rubio,Virginia Calvo,J. Luna,Jordi Remón,M. Martín,Pedro Berraondo,J.R. Jarabo,Oliver Higuera,Esther Conde,Javier de Castro,Mariano Provencio,Florentino Hernándo,Fernando López‐Ríos,Felipe Couñago	2020	9
12	SPARC Expression Did Not Predict Efficacy of nab -Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial Clinical Cancer Research ·Manuel Hidalgo,Carlos Plaza,Mónica Musteanu,Peter B. Illei,Carrie Baker Brachmann,Carla Heise,D. T. Pierce,Pedro P. López‐Casas,Camino Menéndez,Josep Tabernero,Alfredo Romano,Xinyu Wei,Fernando López‐Ríos,Daniel D. Von Hoff	2015	102
13	Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment Clinical Cancer Research ·Elena Garralda,Keren Paz,Pedro P. López‐Casas,Siân Jones,Amanda Katz,Lisa Kann,Fernando López‐Ríos,Francesca Sarno,Fátima Al‐Shahrour,David Vásquez,Elizabeth Bruckheimer,Samuel V. Angiuoli,Antonio Calles,Luis A. Díaz,Victor E. Velculescu,Alfonso Valencia,David Sidransky,Manuel Hidalgo	2014	107
14	Novel Transcriptional Targets of the SRY-HMG Box Transcription Factor SOX4 Link Its Expression to the Development of Small Cell Lung Cancer Cancer Research ·Sandra D. Castillo,Ander Matheu,Niccolò Mariani,Julián Carretero,Fernando López‐Ríos,Robin Lovell‐Badge,Montse Sánchez‐Céspedes	2011	72
15	The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group Lung Cancer ·Erik Thunnissen,Keith M. Kerr,Felix Herth,Sylvie Lantuéjoul,Mauro Papotti,Robert C. Rintoul,Giulio Rossi,Birgit Guldhammer Skov,Birgit Weynand,Lukas Bubendorf,Katrien Grünberg,Leif Johansson,Fernando López‐Ríos,Vincent Ninane,Włodzimierz Olszewski,Helmut Popper,Sauleda Jaume,Philipp A. Schnabel,Luc Thiberville,Florian Laenger	2011	167
16	Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts Molecular Cancer Therapeutics ·Wells A. Messersmith,N.V. Rajeshkumar,Aik Choon Tan,Xiaofei Wang,Veronica Diesl,Sung Choe,Max Follettie,Christina Coughlin,Frank Boschelli,Elena García-García,Fernando López‐Ríos,Antonio Jimeno,Manuel Hidalgo	2009	34
17	Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer Molecular Cancer Therapeutics ·Dongweon Song,Raghothama Chaerkady,Aik Choon Tan,Elena García-García,Anuradha Nalli,Ana Suárez‐Gauthier,Fernando López‐Ríos,Xian Feng Zhang,Anna Solomon,Jeffrey K. Tong,Margaret Read,Christian Fritz,Antonio Jimeno,Akhilesh Pandey,Manuel Hidalgo	2008	68
18	Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction Cancer Research ·Fernando López‐Ríos,Shannon Chuai,Raja M. Flores,Shigeki Shimizu,Takatoshi Ohno,Kazuhiko Wakahara,Peter B. Illei,Sanaa Hussain,Lee M. Krug,Maureen F. Zakowski,Valerie W. Rusch,Adam B. Olshen,Marc Ladanyi	2006	193
19	Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Chronic Heart Failure European Journal of Heart Failure ·Juan F. Delgado,Esther Conde,Violeta Sánchez,Fernando López‐Ríos,Miguel Ángel Gómez‐Sánchez,Pilar Escribano,Teresa Sotelo,Agustı́n Gómez de la Cámara,José Cortina,C.S. de la Calzada	2005	207
20	Squamous Cell Carcinoma Arising in a Cutaneous Epidermal Cyst American Journal of Dermatopathology ·Fernando López‐Ríos,José Luis Rodríguez‐Peralto,Esther Castaño,Amparo Benito	1999	81

About Fernando López‐Ríos

Fernando López‐Ríos is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 177 papers that have together received 6.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (52 papers), Cancer Genomics and Diagnostics (45 papers), Colorectal Cancer Treatments and Studies (17 papers), HER2/EGFR in Cancer Research (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Research Studies (13 papers) and Cancer and Skin Lesions (12 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (3.2k citations) and Pulmonary and Respiratory Medicine (2.7k citations). Fernando López‐Ríos has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Esther Conde, Manuel Hidalgo, Keith M. Kerr, José Luis Rodríguez‐Peralto, Manfred Dietel, Montse Sánchez‐Céspedes, Ana Suárez‐Gauthier, Marc Ladanyi, Reinhard Büttner and Bárbara Angulo. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact